QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 281 filers reported holding QIAGEN NV in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $136,550 | -7.3% | 3,385,274 | +2.3% | 0.32% | -4.8% |
Q2 2023 | $147,357 | +12.7% | 3,307,865 | +14.6% | 0.33% | +0.6% |
Q1 2023 | $130,783 | +40.9% | 2,886,330 | +55.9% | 0.33% | +33.7% |
Q4 2022 | $92,850 | -99.9% | 1,851,924 | -10.6% | 0.25% | -3.1% |
Q3 2022 | $85,814,000 | -12.6% | 2,070,515 | -3.0% | 0.25% | -10.9% |
Q2 2022 | $98,192,000 | +32.5% | 2,134,624 | +43.1% | 0.28% | +57.5% |
Q1 2022 | $74,135,000 | -43.2% | 1,492,049 | -36.1% | 0.18% | -42.9% |
Q4 2021 | $130,507,000 | +25.8% | 2,335,936 | +17.1% | 0.32% | +9.3% |
Q3 2021 | $103,734,000 | +10.2% | 1,993,991 | +4.1% | 0.29% | +5.5% |
Q2 2021 | $94,161,000 | -11.1% | 1,914,948 | -12.9% | 0.28% | -21.9% |
Q1 2021 | $105,965,000 | -16.2% | 2,199,744 | -8.1% | 0.35% | -25.9% |
Q4 2020 | $126,494,000 | -11.4% | 2,394,705 | -12.8% | 0.48% | -25.1% |
Q3 2020 | $142,807,000 | +255.9% | 2,747,350 | +196.6% | 0.63% | +150.6% |
Q2 2020 | $40,129,000 | +0.3% | 926,343 | -6.2% | 0.25% | -17.3% |
Q1 2020 | $40,016,000 | -3.8% | 987,807 | -19.2% | 0.31% | +20.0% |
Q4 2019 | $41,600,000 | – | 1,222,816 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |